Lv3
250 积分 2025-02-24 加入
Novel drug targets and molecular mechanisms for sarcopenia based on systems biology
1个月前
已完结
RNA-sequencing analysis identification of potential biomarkers for diagnosis of sarcopenia
1个月前
已完结
Sarcopenia and MASLD: novel insights and the future
1个月前
已完结
Metabolic reprogramming of immune cells in MASH
1个月前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
1个月前
已完结
Shen-Ling-Bai-Zhu-San Mitigates Ulcerative Colitis by Enhancing Intestinal Barrier Integrity via the AhR-CYP1A1-NF-κB Signal Pathway
1个月前
已完结
Molecular crosstalk and potential causal mechanisms of rheumatoid arthritis and sarcopenia co-morbidity: A gene integration analysis
1个月前
已完结
[Guideline for diagnosis and management of metabolic dysfunction-associated fatty liver disease in primary care (2025)]
2个月前
已完结
[Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (Version 2024)]
2个月前
已完结
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance
2个月前
已完结
皖公网安备34019202002308
